Piper Jaffray Lowers PT on Watson Pharmaceuticals to $73

Symbols: WPI
Share

Piper Jaffray has lowered the price target on Watson Pharmaceuticals (NYSE: WPI) from $78 to $73 and maintains its Overweight rating.


 
 
< Previous
Piper Jaffray Maintains Overweight, $100 PT
Next >
UPDATE: Bank of America Downgrades AllianceBernstein to Underperform
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust